SOMATULINE DEPOT
NDC 15054-1090, lanreotide acetate, injection, from Ipsen Biopharmaceuticals, Inc..
- Product NDC
- 15054-1090
- Status
- Listed
- Labeler
- Ipsen Biopharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022074
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/15054-1090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANREOTIDE ACETATE90 mg/.3mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 15054-1090-4 | 15054109004 | 1 POUCH in 1 CARTON (15054-1090-4) / 1 SYRINGE in 1 POUCH / .3 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6e4a41fd-a753-4362-87ee-8cc56ed3660dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=15054-1090
Use it
Look up 15054-1090 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/15054-1090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 15054-1090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.